Error loading player: No playable sources found

AM24-ST-07-O

AM24-ST-07-O: Preparing for the Data Deluge: Mitigating the Informatics Challenges of Expanded RBC Genotyping Data (Enduring)

Date
October 23, 2024
Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP)
$30
Standard Price
Members save $5
This product is also available as part of the following products:
Thumbnail for 2024 Annual Meeting On-Demand: FULL ACCESS
By far the best value to watch all the on-demand educational sessions from the 2024 AABB Annual Meeting and earn continuing education credit…

Advances in molecular techniques for Red Blood Cell (RBC) genotyping and phenotyping are improving blood transfusion compatibility significantly for Sickle Cell Disease (SCD) patients and others requiring chronic transfusions. This marks a major milestone in transfusion medicine, offering improved patient-donor matching and better outcomes, while it introduces informatics challenges in using patient genotyping information for donor unit selection from inventory. Expanded RBC phenotyping data—which covers over 1,500 genomic features across more than 40 blood group systems—requires sophisticated data management in Electronic Health Records (EHRs), Blood Bank Laboratory Information Systems (BBLIS), and Blood Establishment Computer Systems (BECS). The current systems used by both hospital blood banks and donor centers do not support this level of substantive interoperability. Improving the informatics surrounding expanded phenotyping and genotyping can amplify the benefits of these molecular approaches and drive increased usage. This presentation will use case studies of SCD patients to highlight the benefits of expanded phenotypes in identifying donor units and expose informatics challenges in integrating and sharing this data. It will outline practical solutions for immediate use and future improvements, with an emphasis on standardized vocabulary, shared semantics, interoperability, and the application of machine learning/artificial intelligence for enhanced donor-patient matching. Collaborative innovation in informatics and standardized practices will establish the foundation for the full potential of molecular genotyping. This talk will guide transfusion medicine professionals in navigating these complexities and ensuring that technological progress in genotyping translates into clinical benefits for patients.

Learning Objectives

  • Evaluate the benefits of using genotyping information to better select RBC donor units in select patient populations.
  • Assess the informatics differences in how the EHR, BBLIS, and BECS may represent genotyping information, and how these differences impair interoperability of genotyping information between health systems and blood supplier.
  • Utilize case studies to understand the impact of matching donors for SCD patients.
  • Propose practical solutions for overcoming informatics obstacles in supporting genotyping information, focusing on short term incorporation of genotyping information into your BBLIS, and longer term supporting developing interoperability standards.
  • Evaluate innovative approaches to improve the utilization of molecular genotyping in RBC transfusions.

Speakers

Speaker Image for Marianne Yee
Marianne Yee, MD, MSCR
Emory University and Children's Healthcare of Atlanta
Speaker Image for John Spinosa
John Spinosa, MD, PhD
Lantana Consulting Group

Moderator

Speaker Image for Ross Fasano
Associate Professor, Emory University

Related Products

Thumbnail for AM24-MN-38-O: Turning Over Every Rock: Exploring Advanced Techniques in Platelet and Red Blood Cell Autoantibody Testing (Enduring)
AM24-MN-38-O: Turning Over Every Rock: Exploring Advanced Techniques in Platelet and Red Blood Cell Autoantibody Testing (Enduring)
Autoantibodies to platelets and red blood cells can be clinically pronounced but serologically difficult to detect…
Thumbnail for AM24-MN-24-O: In Limbo with ABO: The Type Discrepancies You’re Probably Seeing But No One is Talking About (Enduring)
AM24-MN-24-O: In Limbo with ABO: The Type Discrepancies You’re Probably Seeing But No One is Talking About (Enduring)
Many common causes of type discrepancies, such as A subgroups, cold-reactive antibodies, and excess serum protein are well-described in literature and well-taught in curricula…
Thumbnail for AM24-MN-04-O: There’s a Blood Donation Bill Proposed to Require WHAT!?—Navigating the Legislative Proposal and Change Process (Enduring)
AM24-MN-04-O: There’s a Blood Donation Bill Proposed to Require WHAT!?—Navigating the Legislative Proposal and Change Process (Enduring)
Today’s leaders increasingly find themselves immersed in the world of legislation and advocacy, which is an unfamiliar space for many…
Thumbnail for AM24-MN-35-O: The Role of Blood Operators and Transfusion Services in Preventing and Responding to Transfusion-transmitted Malaria (Enduring)
AM24-MN-35-O: The Role of Blood Operators and Transfusion Services in Preventing and Responding to Transfusion-transmitted Malaria (Enduring)
Malaria is caused by intra erythrocytic parasites from the genus Plasmodium. In the natural world, Plasmodium is transmitted to humans via the bite of an infected female Anopheles mosquito…